Compare Neurocrine Biosciences Inc (NBIX) vs Nvidia Corp (NVDA) Price & Performance

Neurocrine Biosciences IncTrade

Nvidia CorpTrade

Price performance (Past 24H)

Key statistics

Neurocrine Biosciences Inc vs Nvidia Corp — how do they compare? Neurocrine Biosciences Inc trades at $179 (market cap $17.40B), while Nvidia Corp trades at $206.48 (market cap $4.92T). The key difference: Nvidia Corp is far larger — about 282.8× Neurocrine Biosciences Inc's market cap, and Nvidia Corp pays a 0.49% dividend while Neurocrine Biosciences Inc pays none. Which is the better fit depends on your goals.

	NBIX	NVDA
Market Cap	$17.40B	$4.92T
Sector	Health	Technology
52-Week High	$180.55	$235.75
52-Week Low	$123.10	$165.17
Enterprise Value	$16.49B	$4.86T
Dividend Yield	—	0.49%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Neurocrine Biosciences Inc

No Aura AI signal available yet.

Nvidia Corp

NVIDIA (NVDA) trades at $207.14, up 2.14% today, with a neutral technical signal and strong fundamentals. Recent earnings beats and robust profitability margins highlight operational strength. The stock is supported by a consensus analyst price target of $325.86, though it faces technical resistance near $210.

Outlook remains positive driven by AI chip demand, but risks include competition and market volatility. Revenue growth acceleration and high institutional ownership suggest long-term potential, yet valuation multiples require sustained execution to justify further upside.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NBIX

Neurocrine Biosciences appoints Samir Siddhanti as Chief Business Officer to lead growth strategy.PRNewsWire · 7 hours agoBullish View details →

NVDA

Amplify CWP Growth & Income ETF offers 10.69% yield with tech focus, rated a BUY for income portfolios.Seeking Alpha · 7 hours agoBullish Roundhill Magnificent Seven ETF offers equal exposure to top 7 mega-cap tech stocks but with higher risk and cost.24/7 Wall Street · 7 hours agoNeutral Nvidia faces pressure from cheaper Chinese chips but bets on AI and emerging tech for growthSeeking Alpha · 8 hours agoNeutral View details →

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

About Nvidia Corp

NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.